Carerx Stock Short Ratio
| CHHHF Stock | USD 1.41 0.12 7.84% |
CareRx fundamentals help investors to digest information that contributes to CareRx's financial success or failures. It also enables traders to predict the movement of CareRx Pink Sheet. The fundamental analysis module provides a way to measure CareRx's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CareRx pink sheet.
CareRx |
CareRx Company Short Ratio Analysis
CareRx's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Based on the latest financial disclosure, CareRx has a Short Ratio of 0.0 times. This is 100.0% lower than that of the Food & Staples Retailing sector and about the same as Consumer Staples (which currently averages 0.0) industry. The short ratio for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run My Watchlist Analysis Now
My Watchlist AnalysisAnalyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
| All Next | Launch Module |
CareRx Fundamentals
| Return On Equity | -0.49 | |||
| Return On Asset | 0.0204 | |||
| Profit Margin | (0.09) % | |||
| Operating Margin | 0.02 % | |||
| Current Valuation | 170.84 M | |||
| Shares Outstanding | 51.96 M | |||
| Shares Owned By Insiders | 30.25 % | |||
| Shares Owned By Institutions | 32.82 % | |||
| Price To Earning | 13.57 X | |||
| Price To Book | 1.78 X | |||
| Price To Sales | 0.22 X | |||
| Revenue | 262.63 M | |||
| Gross Profit | 75.28 M | |||
| EBITDA | 6.15 M | |||
| Net Income | (22.73 M) | |||
| Cash And Equivalents | 15.2 M | |||
| Cash Per Share | 0.32 X | |||
| Total Debt | 106.11 M | |||
| Debt To Equity | 2.35 % | |||
| Current Ratio | 1.69 X | |||
| Book Value Per Share | 1.24 X | |||
| Cash Flow From Operations | 7.27 M | |||
| Earnings Per Share | (0.38) X | |||
| Number Of Employees | 1.38 K | |||
| Beta | 0.79 | |||
| Market Capitalization | 101.85 M | |||
| Total Asset | 282.82 M | |||
| Net Asset | 282.82 M |
About CareRx Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CareRx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CareRx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CareRx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Other Information on Investing in CareRx Pink Sheet
CareRx financial ratios help investors to determine whether CareRx Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CareRx with respect to the benefits of owning CareRx security.